Cysteine amino-acid compound (or its analogues) used in the disruption of
microbial biofilms by treatment of prevention of diseases generated by phytopathogenic
bacteria attacking plants of agricultural interest represented by an innovative solution within the
agriculture sector, where said compound can be used in the pharmacological form, as a
drug associated with
fertilizer for the combat of bacterial diseases which form
microbial biofilms, such as citrus variegated
chlorosis (CVC), citric
canker’, huanlongbing (HLB)
disease or ‘
greening’, amongst other, which inventive concept, as such, never before completed, resides in the benefit deriving from the
cysteine amino-acid, and all of its analogues, in the inhibitory action and progressive disruption of the microbial
biofilm thus liberating the nutritive flux and hydration of the root to the upper part of the
plant and the subsequent regression of the
disease symptoms, with the added
advantage that the
cysteine amino-acid compound is non-toxic, guaranteeing healthy production of foods by plants of agricultural interest that are totally healthy, without toxic residues in their composition, as well as when said compound is applied there is risk to the environment due to the rapid absorption, notably within the area in which it is applied, where such predicates of
disease combat, with the exception of toxic collateral effects still guarantee that the final
crop and harvest will have a higher productivity per
hectare.